Accueil > Fr > Rech & Devpt > Publications > 2018

2018

Publications

  1. Comparison of Immuno-PET of CD138 and PET imaging with 64CuCl2 and 18F-FDG in a preclinical syngeneic model of multiple myeloma. Bailly C, Gouard S, Lacombe M, Remaud-Le Saëc P, Chalopin B, Bourgeois M, Chouin N, Tripier R, Halime Z, Haddad F, Faivre-Chauvet A, Kraeber-Bodéré F, Chérel M, Bodet-Milin C, Oncotarget 2018, 9:9061-9072
  2. Synthesis of C-functionalized TE1PA and comparison with its analogues. An example of bioconjugation on 9E7.4 mAb for multiple myeloma 64Cu-PET imaging, Le Bihan T, Navarro AS, Le Bris N, Le Saëc P, Gouard S, Haddad F, Gestin JF, Chérel M, Faivre-Chauvet A, Tripier R Org Biomol Chem. 2018, 16:4261-4271
  3. Alphatherapy, the new impetus to targeted radionuclide therapy ? Chatal JF, Kraeber-Bodéré F, Chérel M, Haddad F, Eur J Nucl Med Mol Imaging 2018, 45:1362-1363
  4. Sensitivity of pretargeted immunoPET using 68Ga-peptide to detect colonic carcinoma liver metastases in a murine xenograft model : Comparison with 18FDG PET-CT, Foubert F, Gouard S, Saï-Maurel C, Chérel M, Faivre-Chauvet A, Goldenberg DM, Barbet J, Bodet-Milin C, Bailly C, Carlier T, Kraeber-Bodéré F, Touchefeu Y, Frampas E. Oncotarget 2018, 9:27502-27513
  5. Promising Scandium Radionuclides for Nuclear Medicine : A Review on the Production and Chemistry up to In Vivo Proofs of Concept, Huclier-Markai S, Alliot C, Kerdjoudj R, Mougin-Degraef M, Chouin N, Haddad F. Cancer Biother Radiopharm. 2018, 33 : 316-329
  6. New production cross section dataset for the relevant theragnostic radionuclide 67Cu. Gaia Pupillo, Thomas Sounalet, Nathalie Michel, Liliana Mou, Juan Esposito and Férid Haddad, NIMB 415 (2018)41:47
  7. Development of an ultra thin beam profiler for charged particle beams. B. Boyer et al. Nuclear Inst. and Methods in Physics Research, A (2018), https://doi.org/10.1016/j.nima.2018.09.134)
  8. Production of Sc medical radioisotopes with proton and deuteron beams. Mateusz Sitarz et al. Applied Radiation and Isotopes, Volume 142, December 2018, Pages 104-112
  9. Theoretical 0-0 energies with chemical accuracy. P.-F. Loos, N. Galland, D. Jacquemin J. Phys. Chem. Lett. (IF : 8.709), 9, 4646-4651 (2018)
  10. Phosphonate-Mediated Immobilization of Rhodium/Bipyridine Hydrogenation Catalysts, F. Forato, A. Belhboub, J. Monot, M. Petit, R. Benoit, V. Sarou-Kanian, F. Fayon, D. Jacquemin, C. Queffelec and B. Bujoli. Chem. Eur. J. 24 (2018) 2457-2465
  11. What is the Key for Accurate Absorption and Emission Calculations, Energy or Geometry ? D. Jacquemin. J. Chem. Theory Comput. 14 (2018) 1534-1543
  12. Excited State Dipole Moments in Solution : Comparison Between State-Specific and Linear-Response TD-DFT Values. C. A. Guido, B. Mennucci, G. Sclamani and D. Jacquemin. J. Chem. Theory Comput. 14 (2018) 1544-1553
  13. Bidirectional Solvatofluorochromism of a Pyrrolo[3,2-$b$]pyrrole-diketopyrrolopyrrole Hybrid. H. G. Ruy, M. F. Mayther, J. Tamayo, C. Azarias, E. M. Espinoza, M. Banasiewicz, L. Lukasiewicz, Y. M. Poronik, A. Jezewski, Y. M. Poronik, J. Clark, J. B. Derr K. H. Ahn, D. T. Gryko, D. Jacquemin and V. I. Vullev. J. Phys. Chem. C 122 (2018) 13424-134340
  14. Accuracy of TD-DFT Geometries : a Fresh Look. E. Bremond, M. Savarese, C. Adamo and D. Jacquemin. J. Chem. Theory Comput. 14 (2018) 3715-3727
  15. The Influence of the Nature of the Amino Group in Highly Fluorescent Difluoroborates Exhibiting Intramolecular Charge Transfer. B. Jedrzejewska, A. Skotnicka, A. D. Laurent, M. Pietrzak, D. Jacquemin and B. Osmialowski. J. Org. Chem. 83 (2018) 7779-7788
  16. Controlling the Canonical/Zwitterionic Balance through Intramolecular Proton Transfer : a Strategy for Vapochromism. S. Pascal, L. Lavaud, C. Azarias, G. Canard, M. Giorgi, D. Jacquemin and O. Siri. Mater. Chem. Front. 2 (2018) 1618-1625
  17. Evidence for the Heaviest Expected Halide Species in Aqueous Solution, At–, by Electromobility Measurements. Julie Champion, Ning Guo, Fabien Pottier, Jean Aupiais, Cyrille Alliot, and Gilles Montavon. Inorganic Chemistry, 57(9):4926-4933, 2018. doi : 10.1021/acs.inorgchem.7b03003.
  18. Experimental and computational evidence of halogen bonds involving astatine. Ning Guo, Rémi Maurice, David Tézé, Jérôme Graton, Julie Champion, Gilles Montavon, and Nicolas Galland. Nature Chemistry, 10(4):428-434, 2018. doi : 10.1038/s41557-018-0011-1.
  19. Quantum calculations of At-mediated halogen bonds : on the influence of relativistic effects.Nicolas Galland, Gilles Montavon, Jean-Yves Le Questel, and J. Graton. New J. Chem. 42:10510-10517, 2018. doi : 10.1039/C8NJ00484F.
  20. Spin-orbit coupling as a probe to decipher halogen bonding. Jérôme Graton, Seyfeddine Rahali, Jean-Yves Le Questel, Gilles Montavon, Julien Pilmé, and Nicolas Galland.. Phys. Chem. Chem. Phys. 20:29616-29624, 2018, doi : 10.1039/C8CP05690K.
  21. Pretargeting in the context of theranostics and companion diagnostics in nuclear oncology. Barbet J. Clin Transl Imaging. (2018) 1-9.
  22. Translational molecular imaging in exocrine pancreatic cancer. Cornelissen B, Knight JC, Mukherjee S, Evangelista L, Xavier C, Caobelli F, Del Vecchio S, Rbah-Vidal L, Barbet J, de Jong M, van Leeuwen FWB. Eur J Nucl Med Mol Imaging. (2018)45, 2442-2455.
  23. Coupling a gamma-ray detector with asymmetrical flow field flow fractionation (AF4) : Application to a drug-delivery system for alpha-therapy. Huclier-Markai S, Grivaud-Le Du A, N’tsiba E, Montavon G, Mougin-Degraef M, Barbet J. J Chromatogr A, (2018)1573, 107-114.
  24. Speciation of technetium in carbonate media under helium ions and γ radiation. Ghalei, M., J. Vandenborre, F. Poineau, G. Blain, P.-L. Solari, J. Rôques, F. Haddad, and M. Fattahi, , in Radiochimica Acta. 2018 Contribution spéciale
  25. European Nuclear Medicine Guide, A joint publication by EANM and UEMS/EBNM, Edited by : Roland Hustinx and Kristoff Muylle. https://www.nucmed-guide.app/#!/home


Communications orales 2018 :

  1. PET Imaging criteria in Myeloma, Kraeber-Bodéré F, 7th international workshop on PET in lymphoma and myeloma PIM, Menton, France, October 5-6 2018 (invited)
  2. PET Imaging criteria in Myeloma, Bodet-Milin C, 7th international workshop on PET in lymphoma and myeloma PIM, Menton, France, October 5-6 2018(invited)
  3. Alpha-radioimmunotherapy, bigger or better ?, Chérel M, Precongress Symposium EANM Alpha-endoradiotherapy in solid tumors, Düsseldorf, Germany, oct 13 2018 (invited)
  4. Synthesis and evaluation of radioiodinated and astatinated prosthetic groups for bioorthogonal conjugation to antibodies for nuclear imaging and therapy. Navarro L, Gouard S, Alliot C, Chérel M, Pecorari F, Guérard F, Gestin JF . ESRR’18 - 19th European Symposium on Radiopharmacy and Radiopharmaceuticals, Groningen, Netherlands, April 5-8, 2018
  5. Efficacy of Astatine-211 radioimmunotherapy of Multiple Myeloma using an anti-mCD138 monoclonal antibody in a syngeneic murine model (OP-508). Gouard S, Chalopin B, Maurel C, Guérard F, Navarro L, Gestin JF, Chouin N, Haddad F, Alliot C, Kraeber-Bodéré F, Davodeau F, Chérel M . EANM’18 31th Annual congress of the European Association of Nuclear Medicine, Dusseldorf, Germany, oct 13-17 2018
  6. Biodistribution, Imaging and Metabolism Studies of 64-Copper Radiolabelled Monoclonal Antibody : Comparison of DOTA and TE1PA Chelating Agents in a Murine Model of Multiple Myeloma (OP-375). Navarro AS, Le Bihan T, Le Saëc P, Gouard S, Le Bris N, Bailly C, Saï-Maurel C, Chalopin B, Gestin JF, Chérel M, Tripier R, Faivre-Chauvet A. EANM’18 31th Annual congress of the European Association of Nuclear Medicine, Dusseldorf, Germany, oct 13-17 2018
  7. PET Imaging of Multiple Myeloma : Comparison of 89Zr- and 64Cu-labeled anti-CD138 Conjugates to 64CuCl2 and 18F-FDG in a Preclinical Syngeneic Model (OP-040). Bailly C, Gouard S, Chalopin B, Carlier T, Maurel C, Remaud-Le Saëc P, Bourgeois M, Chouin N, Tripier R, Haddad F, Faivre-Chauvet A, Kraeber-Bodere F, Bodet-Milin C, Cherel M . EANM’18 31th Annual congress of the European Association of Nuclear Medicine, Dusseldorf, Germany, oct 13-17 2018
  8. Preliminary results of 68Ga-PSMA PET/CT prospective study in prostate cancer occult recurrence patients : diagnostic performance and impact on therapeutic decision-making (OP-042). Rousseau C, Le Thiec M, Ferrer L, Rusu D, Rauscher A, Maucherat B, Frindel M, Baumgartner P, Fleury V, Denis V, Varmenot N, Debeaupuis E, Campion L, Kraeber-Bodéré F . EANM’18 31th Annual congress of the European Association of Nuclear Medicine, Dusseldorf, Germany, oct 13-17 2018
  9. Why should we take care about occupational dosimetric impact when routine use of gallium-68 in nuclear medicine ? A preliminary study (OP-238). Varmenot N, Ferrer L, Frindel M, Rauscher A, Baumgartner P, Delaunay F, Mathey A, Pitel C, Zulian H, Kraeber-Bodéré F, Denis A, Rousseau C . EANM’18 31th Annual congress of the European Association of Nuclear Medicine, Dusseldorf, Germany, oct 13-17 2018
  10. Le scandium : un élément à fort potential pour la médecine nucléaire, Haddad F Club Français des Radiopharmaceutiques, Montpellier, France, May 17-18, 2018 (invited)
  11. Présentation d’Arronax et Production de Radionucléides Médicaux, Haddad F Rencontres Accélérateurs 2018, Saint-Herblain, France, october 8-9 2018. (invited)
  12. Production of alpha emitting isotopes : can we get enough ? Haddad F. Precongress Symposium EANM Alpha-endoradiotherapy in solid tumors, Düsseldorf, Germany, oct 13 2018(invited)
  13. Accelerators and research with non-conventional medical isotopes. Haddad F. ARCEBS-2018, Kolkata, India (November 11-17, 2018) (invited)
  14. M. Bourgeois, The 3rd International Symposium on “Physics, Engineering and Technologies for Biomedicine” Moscou,oct 15-17 2018(invited) 1-# « titre à ajouter » C. Alliot Hunter college, USA
  15. « titre à ajouter » S. Huclier Hunter college USA
  16. Very high specific activity Er169 production, R. Formento et al. Conference EMIS 2018 16-21 septembre (CERN geneve Suisse)
  17. Arronax a facility to produce nonstandard radionuclides and radiopharmaceuticals. 17th International Workshop on Targetry and Target Chemistry (WTTC17), 27-31 Aout 2018
  18. « titre à ajouter » T. Sounalet 17th International Workshop on Targetry and Target Chemistry (WTTC17), 27-31 Aout 2018
  19. Research on production of 97Ru with the use of Radionuclide Yield Calculator at ARRONAX, M. Sitarsz et al. 17th International Workshop on Targetry and Target Chemistry (WTTC17), 27-31 Aout 2018
  20. Production cross section of 197mHg induced by deuterons on natural gold target, E. Nigron, 15th Varenna Conference on Nuclear Reaction Mechanisms, Italie.(11-15 juin 2018 )
  21. Production of medically interesting 97Ru via natMo(α,x) above 40 MeV at ARRONAX, M. Sitarsz, 15th Varenna Conference on Nuclear Reaction Mechanisms, Italie.(11-15 juin 2018 )
  22. Production of innovative radionuclides for therapy or diagnostic : nuclear data measurements and comparisons with the TALYS code. A. Guertin, 15th Varenna Conference on Nuclear Reaction Mechanisms, Italie.(11-15 juin 2018 )
  23. Une vue relativiste de la liaison halogène. N. Galland, J. Pilmé, J. Graton, R. Maurice, G. Montavon. XVIes Rencontres des Chimistes Théoriciens Francophones (RCTF), Toulouse (Haute Garonne), 2018
  24. Astatine : halogen or metal ?G. Montavon, C. Alliot, J. Barbet, J. Champion, M. Chérel, D. Deniaud, F. Guerard, N. Galland, J. F. Gestin, F. Réal, N. Guo, R. Maurice, J. Pilmé, E. Renault, J. Graton, D.-C. Sergentu, D. Teze. 18th Radiochemical Conference (RadChem 2018), Marienbad (République tchèque), 2018
  25. Towards a stronger halogen bond involving At– Investigation of halogen-bonded adducts of AtI and Bu3PO. Lu Liu, Ning Guo, Julie Champion, Jérôme Graton, Gilles Montavon, Nicolas Galland, and Rémi Maurice. In JECRRC-2018, Strasbourg, France, May 2018.
  26. “Radiochimie théorique” : Calculs de chimie quantique et analyses de liaisons chimiques d’intérêt en radiochimie. Rémi Maurice, Florent Réal, Valérie Vallet, and Jérôme Roques In JECRRC-2018, Strasbourg, France, May 2018.
  27. Probing chemical bonds at the relativistic and mul- ticonfigurational level : Effective bond orders and topological analyses.Cecilia Gomez Pech, Pi A. B. Haase, Dumitru-Claudiu Sergentu, Nicolas Galland, Anastasia Borschevsky, Julien Pilmé, and Rémi Maurice. In ESCB2, Oviedo, Spain, September 2018. Invité.
  28. Calculs relativistes pour l’identification de nouvelles espèces chimiques aux ultra-traces. Dumitru-Claudiu Sergentu, Ning Guo, David Teze, Julie Champion, Gilles Montavon, Nicolas Galland, and Rémi Maurice. In Rencontres des Chimistes Théoriciens Francophones, Toulouse, France, October 2018.
  29. Chemical Biology Approaches for the Design of Radiopharmaceuticals. J. Barbet. MEDICIS-Promed Summer School, Cascais, Portugal, 3-6 juin 2018.(invited)
  30. Radiochimie à SUBATECH : Le dihydrogène un lien quasi évident », JECRRC, 01-07 Juin 2018, Strasbourg
  31. « Formation et dégradation des anions organiques en milieu carbonate sous irradiation par faisceau d’hélions. » A.Costagliola, J.Vandenborre, G.Blain, F.Haddad, M.Fattahi, , JECRRC, 01-07 Juin 2018, Strasbourg
  32. La radiolyse de l’eau peut-elle servir la radiothérapie vectorisée ? Amaury COSTAGLIOLA, Guillaume BLAIN, Johan. VANDENBORRE, Massoud FATTAHI. Les journées scientifiques de l’Université de Nantes. 01 juin 2018. La Cité. Centre des congrès. Nantes

Posters :

  1. Synthesis and evaluation of radioiodinated and astatinated prosthetic groups for bioorthogonal conjugation to antibodies for nuclear imaging and therapy, Navarro L, Gouard S, Alliot C, Chérel M, Pecorari F, Guérard F, Gestin JF, ESRR’18 - 19th European Symposium on Radiopharmacy and Radiopharmaceuticals, Groningen, Netherlands, April 5-8, 2018
  2. Bioorthogonal chemistry applied to bispecific antibody manufacturing, Navarro L, Remaud-Le Saëc P, Navarro AS, Mougin-Degraef M, Guerard F, Gestin JF, Chérel M, Faivre-Chauvet A, ESRR’18 - 19th European Symposium on Radiopharmacy and Radiopharmaceuticals, Groningen, Netherlands, April 5-8, 2018
  3. PET imaging of multiple myeloma : Comparison of 89Zr- and 64Cu-labeled anti-CD138 conjugates to 64CuCl2 and 18F-FDG in a preclinical syngeneic model. Bailly C, Gouard S, Chalopin B, Carlier T, Maurel C, Remaud-Le Saëc P, Bourgeois M, Chouin N, Tripier R, Haddad F, Faivre-Chauvet A, Kraeber-Bodéré F, Bodet-Milin C, Chérel M, 7th international workshop on PET in lymphoma and myeloma PIM, Menton, France, October 5-6 2018
  4. Preliminary results of prognostic added value of PET textural features at diagnosis in multiple myeloma with a long-term follow-up, Carlier T, Jamet B, Bailly C, Touzeau C, Moreau P, Bodet-Milin C, Kraeber-Bodéré F, 7th international workshop on PET in lymphoma and myeloma PIM, Menton, France, October 5-6 2018
  5. A population pharmacokinetics approach to evaluate the impact of the antibody dose in a context of lymphoma radioimmunotherapy (RIT) on dogs, Morio-Etienne F, Rajaud M, Becavin S, Piccirillo E, Touzot-Jourde G, Vidal A, Bourgeois M, Nguyen F, Abadie J, Varmenot N, Ferrer L, Bodet-Milin C, Ibisch C, Barbet J, Davodeau F, Chouin N, EANM’18 31th Annual congress of the European Association of Nuclear Medicine, Dusseldorf, Germany, oct 13-17 2018
  6. G.Blain, J.Vandenborre, A.Costagliola, F.Haddad, M.Fattahi, « La Radiolyse α Pulsée en radiochimie : De la radiolyse de l’eau vers de nombreuses applications en radiochimie », JECRRC, 01-07 Juin 2018, Strasbourg